GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (OTCPK:RCDTF) » Definitions » Operating Margin %

Recordati SpA (Recordati SpA) Operating Margin % : 23.08% (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Recordati SpA Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Recordati SpA's Operating Income for the three months ended in Dec. 2023 was $132 Mil. Recordati SpA's Revenue for the three months ended in Dec. 2023 was $574 Mil. Therefore, Recordati SpA's Operating Margin % for the quarter that ended in Dec. 2023 was 23.08%.

Warning Sign:

Recordati SpA operating margin has been in a 5-year decline. The average rate of decline per year is -4.2%.

The historical rank and industry rank for Recordati SpA's Operating Margin % or its related term are showing as below:

RCDTF' s Operating Margin % Range Over the Past 10 Years
Min: 23.79   Med: 30.59   Max: 32.96
Current: 27.17


RCDTF's Operating Margin % is ranked better than
93.33% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 6.13 vs RCDTF: 27.17

Recordati SpA's 5-Year Average Operating Margin % Growth Rate was -4.20% per year.

Recordati SpA's Operating Income for the three months ended in Dec. 2023 was $132 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was $610 Mil.


Recordati SpA Operating Margin % Historical Data

The historical data trend for Recordati SpA's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA Operating Margin % Chart

Recordati SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.70 32.71 31.98 26.67 27.17

Recordati SpA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.50 32.07 28.57 24.74 23.08

Competitive Comparison of Recordati SpA's Operating Margin %

For the Drug Manufacturers - General subindustry, Recordati SpA's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Recordati SpA's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Recordati SpA's Operating Margin % falls into.



Recordati SpA Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Recordati SpA's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=616.976 / 2270.808
=27.17 %

Recordati SpA's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=132.457 / 573.781
=23.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Recordati SpA  (OTCPK:RCDTF) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Recordati SpA Operating Margin % Related Terms

Thank you for viewing the detailed overview of Recordati SpA's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Recordati SpA (Recordati SpA) Business Description

Traded in Other Exchanges
Address
Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.

Recordati SpA (Recordati SpA) Headlines

From GuruFocus

Recordati: Isturisa® (Osilodrostat) Approved In The U.S.

By PRNewswire PRNewswire 03-09-2020